journal
MENU ▼
Read by QxMD icon Read
search

American Journal of Gastroenterology

journal
https://www.readbyqxmd.com/read/30333551/web-based-model-for-predicting-time-to-surgery-in-young-patients-with-familial-adenomatous-polyposis-an-internally-validated-study
#1
Shashank Sarvepalli, Carol A Burke, Marc Monachese, Rocio Lopez, Brandie H Leach, Lisa Laguardia, Margaret O'Malley, Matthew F Kalady, James M Church
INTRODUCTION: The timing of prophylactic colorectal surgery in patients with familial adenomatous polyposis (FAP) is based on the immediacy of the colorectal cancer risk. The ability to predict the need for surgery may help patients and their families plan in the context of life events and CRC risk. We created a model to predict the likelihood of surgery within 2 and 5 years of first colonoscopy at our institution. METHODS: A single institution hereditary colorectal syndrome (Cologene™) database was interrogated for all patients with FAP having a deleterious APC mutation...
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333550/discussion-of-code-status-in-the-peri-endoscopic-period
#2
Vijaya L Rao, Lauren D Feld, David T Rubin
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333549/response-to-kosmidou-et-al
#3
LETTER
Prasad G Iyer, David A Ahlquist
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333548/bloody-versus-coffee-grounds-hematemesis-which-is-more-severe
#4
LETTER
Ji Feng, Lei Liu, Xiaozhong Guo, Xingshun Qi
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333547/dna-methylation-biomarkers-for-the-diagnosis-of-barrett-s-oesophagus
#5
LETTER
Cassandra Kosmidou, Sriganesh Jammula, Rebecca C Fitzgerald
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333546/comment-on-2018-acg-clinical-guideline-antibiotics-in-crohn-s-disease
#6
LETTER
William Chamberlin, Thomas Borody
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333545/mucinous-small-bowel-adenocarcinoma-mimicking-change-to-internal-penetrating-phenotype-in-well-controlled-crohn-s-disease
#7
LETTER
Ankita Tirath, George P Christophi, Tyler J Fraum, Deyali Chatterjee, Parakkal Deepak
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333544/wine-consumption-and-lower-risk-of-advanced-liver-fibrosis-a-true-effect-or-unmeasured-confounding-a-longitudinal-analysis-anrs-co13-hepavih-cohort
#8
LETTER
Fabienne Marcellin, Marie Costa, Linda Wittkop, Camelia Protopopescu, Laure Esterle, Dominique Salmon-Ceron, Philippe Sogni, Maria Patrizia Carrieri
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333543/trends-in-chronic-liver-disease-related-hospitalizations-a-population-based-study
#9
Sumeet K Asrani, Lauren Hall, Michael Hagan, Sushma Sharma, Samrat Yeramaneni, James Trotter, Jayant Talwalkar, Fasiha Kanwal
OBJECTIVES: In a population-based study, we examined time trends in chronic liver disease (CLD)-related hospitalizations in a large and diverse metroplex. METHODS: We examined all CLD-related inpatient encounters (2000-2015) in Dallas-Fort Worth (DFW) using data from the DFW council collaborative that captures claims data from 97% of all hospitalizations in DFW (10.7 million regional patients). RESULTS: There were 83,539 CLD-related hospitalizations in 48,580 unique patients across 84 hospitals...
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333542/clinical-features-associated-with-survival-outcome-in-african-american-patients-with-hepatocellular-carcinoma
#10
Jacqueline Estevez, Ju Dong Yang, Jennifer Leong, Pauline Nguyen, Nasra H Giama, Ning Zhang, Hamdi A Ali, Mei-Hsuan Lee, Ramsey Cheung, Lewis Roberts, Myron Schwartz, Mindie H Nguyen
BACKGROUND: African-Americans (AA) have a higher incidence of hepatocellular carcinoma (HCC) and lower survival. We characterized survival rates and clinical features associated with survival in AA vs. Caucasians with HCC over the past two decades. METHODS: HCC patients from three US medical centers were matched by year of diagnosis (1991-2016): AA (n = 578)/Caucasian (n = 578) and placed in one of two groups-HCC diagnosed prior to 2010 or 2010 and after...
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333541/safety-and-tolerability-of-accelerated-infliximab-infusions-in-patients-with-inflammatory-bowel-disease
#11
Danning Ma, Wendy Wong, Jeremie Aviado, Cesar Rodriguez, Helen Wu
INTRODUCTION: Infliximab for inflammatory bowel disease (IBD) is FDA-approved to be administered 2 h or more. We adopted a new protocol to infuse infliximab over 1 h and in this study, we aimed to determine the safety of a 1-h infusion. METHODS: This retrospective cohort included adult IBD patients who received infliximab between June and December 2017 and compared reaction rates of 1-h maintenance infusions to that of 2-h maintenance infusions. RESULTS: A total of 551 infusions were administered to 179 patients...
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333540/olga-gastritis-staging-for-the-prediction-of-gastric-cancer-risk-a-long-term-follow-up-study-of-7436-patients
#12
Massimo Rugge, Robert M Genta, Matteo Fassan, Elisa Valentini, Irene Coati, Stefano Guzzinati, Edoardo Savarino, Manuel Zorzi, Fabio Farinati, Peter Malfertheiner
OBJECTIVES: Gastritis OLGA-staging ranks the risk for gastric cancer (GC) in progressive stages (0-IV). This long-term follow-up study quantifies the GC risk associated with each OLGA stage. METHODS: Consecutive patients (7436) underwent esophagogastroscopy (T-0), with mapped gastric biopsies, OLGA staging, and H. pylori status assessment. Patients with neoplastic lesion (invasive or non-invasive) at the index endoscopy (and/or within 12 months) were excluded. All patients were followed-up (T-1) by combining different sources of clinical/pathological information (Regional Registries of: (i) esophagogastroduodenoscopies; (ii) pathology reports; (iii) cancer, (iv) mortality)...
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333539/the-do-s-and-don-ts-of-social-media-a-guide-for-gastroenterologists
#13
Mohammad Bilal, Sasha Taleban, Jonathan Riegler, Christina Surawicz, Andrew Feld
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333538/malignancies-in-inflammatory-bowel-disease-frequency-incidence-and-risk-factors-results-from-the-swiss-ibd-cohort-study
#14
Sylvie Scharl, Christiane Barthel, Jean-Benoit Rossel, Luc Biedermann, Benjamin Misselwitz, Alain M Schoepfer, Alex Straumann, Stephan R Vavricka, Gerhard Rogler, Michael Scharl, Thomas Greuter
BACKGROUND: Malignancy may occur as long-term complication of inflammatory bowel disease (IBD) due to different risk factors. We assessed prevalence and incidence of malignancy, and predictive factors in the Swiss IBD Cohort Study (SIBDCS). METHODS: All IBD patients in the SIBDCS were analyzed from a cross-sectional and longitudinal perspective. Patients with malignancies were compared to controls. Standardized incidence ratios (SIR) were calculated based on age-specific and sex-specific background rates...
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333537/eus-guided-biliary-drainage-versus-ercp-for-the-primary-palliation-of-malignant-biliary-obstruction-an-unfair-comparison
#15
LETTER
Marco Spadaccini, Alessandro Fugazza, Edoardo Troncone, Vincenzo Craviotto, Ferdinando D'Amico, Laura Lamonaca, Andrea Anderloni, Alessandro Repici
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333536/trick-or-treat-more-safety-data-of-infliximab-during-pregnancy
#16
EDITORIAL
Sunanda Kane
Infliximab was the first FDA approved biologic for the treatment of Crohn's disease. Data for its use before and during pregnancy in both females and males have been increasing over the last decade, but most studies have had fewer than 100 patients and inconsistent comparison to healthy control outcomes. New data from the TREAT Safety Registry have a robust N of female and male patients exposed to infliximab with known birth outcomes from both academic and community settings. There does not appear to be any increase in adverse pregnancy outcomes from this population...
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333535/taenia-species-uterine-branches-and-capsule-endoscopy
#17
LETTER
Maria Teresa Galán-Puchades, Màrius V Fuentes
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333534/evanescent-colon-masses-due-to-colon-ischemia
#18
Joseph C Yarze
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333533/an-unexpected-colonic-mass
#19
LETTER
Andrew A Li, George Cholankeril, Gerard J Berry, Nielsen Fernandez-Becker
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/30333532/outcomes-with-bloody-vs-coffee-grounds-hematemesis
#20
LETTER
Loren Laine, Stig B Laursen, Adrian J Stanley
No abstract text is available yet for this article.
October 17, 2018: American Journal of Gastroenterology
journal
journal
20266
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"